These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 9215092

  • 1. Valaciclovir versus aciclovir in patient initiated treatment of recurrent genital herpes: a randomised, double blind clinical trial. International Valaciclovir HSV Study Group.
    Bodsworth NJ, Crooks RJ, Borelli S, Vejlsgaard G, Paavonen J, Worm AM, Uexkull N, Esmann J, Strand A, Ingamells AJ, Gibb A.
    Genitourin Med; 1997 Apr; 73(2):110-6. PubMed ID: 9215092
    [Abstract] [Full Text] [Related]

  • 2. Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. International Valaciclovir HSV Study Group.
    Patel R, Bodsworth NJ, Woolley P, Peters B, Vejlsgaard G, Saari S, Gibb A, Robinson J.
    Genitourin Med; 1997 Apr; 73(2):105-9. PubMed ID: 9215091
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. The Valaciclovir International Study Group.
    Tyring SK, Douglas JM, Corey L, Spruance SL, Esmann J.
    Arch Dermatol; 1998 Feb; 134(2):185-91. PubMed ID: 9487210
    [Abstract] [Full Text] [Related]

  • 5. Valaciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections.
    Perry CM, Faulds D.
    Drugs; 1996 Nov; 52(5):754-72. PubMed ID: 9118821
    [Abstract] [Full Text] [Related]

  • 6. Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection. Results of an international, multicenter, double-blind, randomized clinical trial. The Valaciclovir International Herpes Simplex Virus Study Group.
    Fife KH, Barbarash RA, Rudolph T, Degregorio B, Roth R.
    Sex Transm Dis; 1997 Sep; 24(8):481-6. PubMed ID: 9293612
    [Abstract] [Full Text] [Related]

  • 7. Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections.
    Ormrod D, Scott LJ, Perry CM.
    Drugs; 2000 Apr; 59(4):839-63. PubMed ID: 10804039
    [Abstract] [Full Text] [Related]

  • 8. Aborted genital herpes simplex virus lesions: findings from a randomised controlled trial with valaciclovir.
    Strand A, Patel R, Wulf HC, Coates KM, International Valaciclovir HSV Study Group.
    Sex Transm Infect; 2002 Dec; 78(6):435-9. PubMed ID: 12473805
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Valaciclovir versus aciclovir for herpes simplex virus infection in HIV-infected individuals: two randomized trials.
    Conant MA, Schacker TW, Murphy RL, Gold J, Crutchfield LT, Crooks RJ, International Valaciclovir HSV Study Group.
    Int J STD AIDS; 2002 Jan; 13(1):12-21. PubMed ID: 11802924
    [Abstract] [Full Text] [Related]

  • 11. Single-day, patient-initiated famciclovir therapy versus 3-day valacyclovir regimen for recurrent genital herpes: a randomized, double-blind, comparative trial.
    Abudalu M, Tyring S, Koltun W, Bodsworth N, Hamed K.
    Clin Infect Dis; 2008 Sep 01; 47(5):651-8. PubMed ID: 18637755
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. One-day regimen of valacyclovir for treatment of recurrent genital herpes simplex virus 2 infection.
    Bavaro JB, Drolette L, Koelle DM, Almekinder J, Warren T, Tyring S, Wald A.
    Sex Transm Dis; 2008 Apr 01; 35(4):383-6. PubMed ID: 18362859
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of Pritelivir Compared With Valacyclovir on Genital HSV-2 Shedding in Patients With Frequent Recurrences: A Randomized Clinical Trial.
    Wald A, Timmler B, Magaret A, Warren T, Tyring S, Johnston C, Fife K, Selke S, Huang ML, Stobernack HP, Zimmermann H, Corey L, Birkmann A, Ruebsamen-Schaeff H.
    JAMA; 2016 Dec 20; 316(23):2495-2503. PubMed ID: 27997653
    [Abstract] [Full Text] [Related]

  • 17. Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients.
    Le Cleach L, Trinquart L, Do G, Maruani A, Lebrun-Vignes B, Ravaud P, Chosidow O.
    Cochrane Database Syst Rev; 2014 Aug 03; 2014(8):CD009036. PubMed ID: 25086573
    [Abstract] [Full Text] [Related]

  • 18. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
    Sperling RS, Fife KH, Warren TJ, Dix LP, Brennan CA.
    Sex Transm Dis; 2008 Mar 03; 35(3):286-90. PubMed ID: 18157071
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of valacyclovir for the suppression and episodic treatment of herpes simplex virus in patients with HIV.
    Warren T, Harris J, Brennan CA.
    Clin Infect Dis; 2004 Nov 01; 39 Suppl 5():S258-66. PubMed ID: 15494897
    [Abstract] [Full Text] [Related]

  • 20. Valacyclovir for episodic treatment of genital herpes: a shorter 3-day treatment course compared with 5-day treatment.
    Leone PA, Trottier S, Miller JM.
    Clin Infect Dis; 2002 Apr 01; 34(7):958-62. PubMed ID: 11880962
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.